Patient Safety Still the Main Reason for Reporting of Serious Breaches
The annual review of MHRA´s GCP referrals has recently been published. In 2019, the MHRA received a total of 112 serious breach notifications, of which patient safety was the main reason for the reporting of serious breaches followed by scientific value and data credibility. This is similar to MHRA´s 2018 report.
In addition, the agency updated the notification form (Serious Breach form) and the associated guidance document.
MHRA´s Common Queries
The MHRA notes that the initial notification of a serious breach must be submitted within 7 days of first awareness. Thus, the agency expects that details and information may be incomplete at that point. However, follow-up reports should provide complete information, including, for example:
- Impact assessment, methodology and outcome,
- Investigation whether the issue happened at other sites / on other trials,
- Root cause assessments and CAPAs,
- Documentation of the issue in the (electronic) Trial Master Files (eTMFs) and in the Clinical Study Reports.
More information can be found on MHRA´s blog "GCP Serious Breaches Update".
Related GMP News
25.06.2025Is Knowledge Management a Part of the Pharmaceutical Quality System?
11.06.2025Swissmedic differentiates GMP Scope for Manufacturing and Preparation for Administration
28.05.2025A View on the EU Critical Medicines Act to secure Pharma Supply Chains
20.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review